Daiichi Sankyo Europe GmbH

Featured Stories

For the last eight years Daiichi Sankyo has supported young graduates in Pharmaceutical Sciences from the Ludwig-Maximilians-University in Munich (LMU). In 2016 Martina Meßner was awarded the "Master Prize" read more...

The new Daiichi Sankyo Group’s Value Report is now available! The report includes business facts & figures, information about Daiichi Sankyo’s growth potential, CSR activities and much more. read more...

Featured News

Date	Description
11/05/2017 Research	Daiichi Sankyo Initiates ENVISAGE-TAVI AF Study Investigating Once-Daily LIXIANA®▼ (edoxaban) in Patients with Atrial Fibrillation Undergoing Transcatheter Aortic Valve Implantation	PDF
31/03/2017 Products	Daiichi Sankyo Initiates ELIMINATE-AF Study Investigating Once-Daily Lixiana® (edoxaban) in Patients Undergoing Catheter Ablation of Non-valvular Atrial Fibrillation	PDF
31/01/2017 Research	New analysis demonstrates that insulin-requiring diabetes increases the risk of stroke or systemic embolism in patients with atrial fibrillation	PDF
08/12/2016 Products	Daiichi Sankyo Announces Initiation of Real-World Study in LIXIANA®▼ (edoxaban) Patients Undergoing Diagnostic and Therapeutic Procedures in NVAF and VTE	PDF
07/11/2016 Products	Daiichi Sankyo Announces New Subgroup Analyses of Once-Daily LIXIANA®▼ (edoxaban) in Patients with Non-valvular Atrial Fibrillation to be Presented at AHA Scientific Sessions 2016	PDF
show all

Dear User, This website provides you with information only for healthcare professionals. According to the drug promotion code, we are only able to allow healthcare professionals like physicians and pharmacists to have full access to our website. To visit our page please login.

Daiichi Sankyo
Doc Check

Support for Young Talents

Value Report 2016